Results 111 to 120 of about 1,235 (170)

[Diabetic cardiomyopathy: a focus on sodium-glucose cotransporter type 2 inhibitors]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Guerrero-Barrios S   +5 more
europepmc   +1 more source

[ROX index to predict failure with low flow devices in COVID-19]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc, 2023
Olivares-Melgoza FM   +2 more
europepmc   +1 more source

[Main clinical factors associated with hypoglycemia in patients with type 2 diabetes]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Sánchez-González BDC   +6 more
europepmc   +1 more source

COVID-19 and type 2 diabetes mellitus: implications in pancreatic beta cells. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Sánchez-Cervantes IG   +4 more
europepmc   +1 more source

[Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19]. [PDF]

open access: yesEndocrinol Diabetes Nutr, 2022
Carrasco-Sánchez FJ   +7 more
europepmc   +1 more source

Consequences of COVID-19 on people with diabetes. [PDF]

open access: yesEndocrinol Diabetes Nutr (Engl Ed), 2020
Bellido V, Pérez A.
europepmc   +1 more source

Home - About - Disclaimer - Privacy